Dr. Lal PathLabs Limited (NSEI:LALPATHLAB) is looking for inorganic opportunity. Om Prakash Manchanda, Managing Director, said "The cash on the books, yes, I think the primary objective is to utilize it for growth, both organic and inorganic. Since our business organically does not require too much of capital, so we will primarily use this for inorganic and we are still digesting our last acquisition that we did in Bombay.
So as this stabilizes, the new opportunity comes up, we'll always be open to look at inorganic opportunity".
Dr. Lal PathLabs Limited is an India-based company that is engaged in providing diagnostic and related healthcare tests and services. The Company is engaged in the business of running laboratories for carrying out pathological investigations of various branches of biochemistry, hematology, histopathology, microbiology, electrophoresis, immuno-chemistry, immunology, virology, cytology, and other pathological and radiological investigations. It offers a range of tests by condition, which includes allergy, diabetes, health checkups, viral infections, fever, heart diseases, hypertension, cancer, abortions, anemia, arthritis, breast cancer, diphtheria, disorder of the liver, disorders of bone, drugs of abuse, infertility, lymphoma, tuberculosis, ovarian cancer, osteoporosis, multiple sclerosis, muscular disorder, and viral infections. The Companyâs subsidiaries include Paliwal Diagnostics Private Limited, Paliwal Medicare Private Limited, and Dr. Lal PathLabs Nepal Private Limited.
DR. LAL PATHLABS LIMITED 
